Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study
The Oncologist · 2025
DOI: 10.1093/oncolo/oyae334 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Oncologist, 2025. Verfasst von Javier Trujillo-Santos und 22 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Santa Lucía General University Hospital, Catholic University of Murcia, 30202 Murcia, Spain. Hauptthemen laut MEDLINE: Neoplasms, Venous Thromboembolism. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Venous thromboembolism (VTE) is one of the leading causes of death in patients with cancer. Currently, there is a need to develop an easily applicable risk model that can identify patients who will benefit from receiving primary thromboprophylaxis to reduce the incidence of VTE. Patients and methods This was a non-interventional, multicenter, observational, prospective study carried out in 62 Oncology and Hematology services in Spain and Portugal between January 2018 and December 2019. The main objective of the CARTAGO study was to develop a predictive model within a competitive risk framework to assess the risk of VTE in patients with cancer undergoing chemotherapy, biological, or hormonal treatment.
Results
A total of 1596 patients were analyzed. VTE events occurred in 124 (8%) during the 6-month follow-up period (42% of deep vein thrombosis [DVT], 48% of pulmonary embolism [PE], and 10% of both DVT and PE). Four variables were selected for the multivariate predictive model to determine the risk of VTE (tumor type, D-dimer, compression of a vessel by the tumor, and leukocyte count). The 4 variables were associated with an increased risk of VTE (C-statistic, 0.646 [95%CI, 0.620-0.673]). The most significant variables in the internal validation with bootstrapping were the “very high risk” tumors (hazard ratio [HR] 2.032; 95%CI, 1.287-3.211).
Conclusion
The CARTAGO model predicts the VTE risk in patients with cancer receiving anticancer therapy in an outpatient setting. This model can easily aid in identifying ambulatory patients who would probably benefit from primary thromboprophylaxis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Department, Santa Lucía General University Hospital, Catholic University of Murcia, 30202 Murcia, Spain.
- Medical Oncology Department, General University Hospital of Toledo, 45007 Toledo, Spain.
- Medical Oncology Department, Ourense University Hospital Complex, 32005 Ourense, Spain.
- Santo António University Hospital Centre, School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4099-001 Porto, Portugal.
- Medical Oncology Service, Marqués de Valdecilla University Hospital, Valdecilla Research Institute (IDIVAL), 39008 Santander, Spain.
- Medical Oncology Department, Príncipe de Asturias Teaching Hospital, 28805 Alcalá de Henares, Spain.
ORCID-Profile: Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado, António Araújo, Eva Martínez-de-Castro, Raquel Molina, Victoria E Castellón-Rubio, Pere Domènech, Enrique Gallardo, Esteve Colomé, Ferran Torres, José-Carlos Benítez-Montañez, Rut Porta, Míriam Lobo-de-Mena, Mariana Malheiro, Carme Font, Elena Brozos-Vázquez, Fernando Garicano, Víctor Sapena, Pablo Cerezuela
Zitieren
APA
Trujillo-Santos, J., García-Escobar, I., Salgado, M., Araújo, A., Martínez-de-Castro, E., Molina, R., Castellón-Rubio, V. E., Domènech, P., Gallardo, E., Colomé, E., Torres, F., Benítez-Montañez, J. C., Porta, R., Lobo-de-Mena, M., Malheiro, M., Font, C., Brozos-Vázquez, E., Garicano, F., Sapena, V., …, & CARTAGO Study Group (2025). Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study. The Oncologist. https://doi.org/10.1093/oncolo/oyae334
Vancouver
Trujillo-Santos J, García-Escobar I, Salgado M, Araújo A, Martínez-de-Castro E, Molina R, et al. Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study. The Oncologist. 2025. doi:10.1093/oncolo/oyae334
BibTeX
@article{TrujilloSantos2025,
author = {Trujillo-Santos, Javier and García-Escobar, Ignacio and Salgado, Mercedes and Araújo, António and Martínez-de-Castro, Eva and Molina, Raquel and Castellón-Rubio, Victoria E and Domènech, Pere and Gallardo, Enrique and Colomé, Esteve and Torres, Ferran and Benítez-Montañez, José-Carlos and Porta, Rut and Lobo-de-Mena, Míriam and Malheiro, Mariana and Font, Carme and Brozos-Vázquez, Elena and Garicano, Fernando and Sapena, Víctor and Costa, Ana-Lucia and Albuquerque, Ana-Cristina and Cerezuela, Pablo and CARTAGO Study Group, CARTAGO Study Group},
title = {Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyae334}
}
EUVIMED